Full-Time
Pharmaceutical Sales Representative
Primary Care
Prism Biotech
Prelaunch prescriber profiling and targeting
Compensation Overview
$87k - $118.2k/yr
State College, PA, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to Prism Biotech
See people who can refer or advise you
- Ability to quickly gain understanding of behavioral health and psychiatric disease states, products, market dynamics, and practice settings.
- Ability to comprehend product knowledge, clinical studies, protocols, and guidelines and use that knowledge to deliver information in a sales environment.
- Ability to understand and communicate highly scientific and technical medical information.
- Excellent communication and interpersonal skills.
- Demonstrated success in persuasion, influence, and negotiation skills.
- Documented leadership ability.
- Effective administrative and organizational skills, including proficiency with Microsoft Office.
- Function independently with a high degree of initiative, entrepreneurship, and autonomy while achieving short- and long-term goals.
- Develop and execute territory pharmaceutical sales business plans for assigned brands while achieving consistent sales growth within the territory.
- Promote pharmaceutical products ethically and in compliance with the company’s sales process and approved marketing strategy.
- Build and maintain strong pharmaceutical sales relationships with key customers across multiple settings.
- Meet physician and patient needs while developing strong and lasting relationships with healthcare providers and their staff.
- Some sales experience is preferred but not required for entry-level candidates.
Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Merion Township, Pennsylvania
Founded
2019
Get referred to Prism Biotech
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ono paid an initial milestone in November 2025, proving partner monetization.
- Receptor.AI partnership on March 12, 2026 expands PRISM into AI-guided discovery.
- Eisai presented E7386 preclinical and Phase 1 results in 2026, strengthening credibility.
What critics are saying
- Servier terminated its collaboration and licensing agreement with PRISM BioLab in 2026.
- Boehringer Ingelheim agreement expired in 2026, shrinking partnered revenue optionality.
- PRISM depends on external partnerships; a pipeline failure would crush Japan-listed growth equity valuation.
What makes Prism Biotech unique
- PepMetics® targets intracellular PPIs and membrane proteins using orally available small molecules.
- Eisai and PRISM co-created E7386, validating PRISM’s chemistry in oncology.
- PRISM licenses platform discovery across pharma partners, not just single in-house programs.
Help us improve and share your feedback! Did you find this helpful?